True Wealth Design’s Abivax ABVX Stock Holding History

True Wealth Design’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$933	Buy	+7	New	+$792	﹤0.01%	2005

Other funds holding ABVX

Andera Partners Paris $206M AUM

Syquant Capital SAS Paris, France $447M AUM 13.04% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Burns Matteson Capital Management Corning, New York $320M AUM 71.11% 1-Year Est. Return

SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

QP Wealth Management Eatontown, New Jersey $70.1M AUM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

True Wealth Design's ABVX Position: Q2 2026 in Review

True Wealth Design opened a new position in Abivax (ABVX) in Q2 2026: 7 shares worth $933. The stake represents ﹤0.01% of the portfolio and ranks #2005 among its holdings.

29 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

True Wealth Design held 7 shares of Abivax worth $933 as of Q2 2026.
Abivax was a new True Wealth Design position in Q2 2026.
Abivax made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2005 holding.
29 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.